Most just lately, it's been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in similar locations as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors, this receptor acts for a scavenger https://rogert096svv7.wikiexcerpt.com/user